Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$443M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$224M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Walt Disney
DIS
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$356M |
| 2 |
Union Pacific
UNP
|
+$330M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$213M |
| 4 |
Automatic Data Processing
ADP
|
+$164M |
| 5 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$97.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.61% |
| 2 | Financials | 13.9% |
| 3 | Healthcare | 13% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Ramaco Resources Class A
METC
$629M
| $163K | ﹤0.01% |
28,877
+571
| +2% | +$3.11K |
|
3052
Aquestive Therapeutics
AQST
$452M
| $162K | ﹤0.01% |
+23,379
| New | +$164K |
|
|
AMPE
3053
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $160K | ﹤0.01% |
949
+245
| +35% | +$42K |
|
|
NWHM
3054
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $160K | ﹤0.01% |
33,510
+9,661
| +41% | +$57.8K |
|
3055
Dawson Geophysical
DWSN
$130M
| $159K | ﹤0.01% |
54,133
+14,633
| +37% | +$52.5K |
|
3056
Larimar Therapeutics
LRMR
$377M
| $159K | ﹤0.01% |
4,814
-834
| -15% | -$42.8K |
|
3057
Vuzix
VUZI
$178M
| $159K | ﹤0.01% |
51,800
| – | – |
|
|
AMR
3058
DELISTED
Alta Mesa Resources Inc
AMR
| $158K | ﹤0.01% |
593,864
+42,195
| +8% | +$31.9K |
|
3059
Mustang Bio
MBIO
$4.39M
| $150K | ﹤0.01% |
58
+16
| +38% | +$45.3K |
|
3060
NLI Holdings
NL
$289M
| $150K | ﹤0.01% |
38,478
+790
| +2% | +$3.23K |
|
3061
Sutro Biopharma
STRO
$386M
| $150K | ﹤0.01% |
1,311
| – | – |
|
3062
Capital Bancorp
CBNK
$616M
| $146K | ﹤0.01% |
12,520
| – | – |
|
3063
Corvus Pharmaceuticals
CRVS
$1.1B
| $146K | ﹤0.01% |
36,275
+10,375
| +40% | +$43.8K |
|
|
AMRS
3064
DELISTED
Amyris Inc.
AMRS
| $143K | ﹤0.01% |
68,297
-1,823
| -3% | -$7.2K |
|
|
RVLP
3065
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $140K | ﹤0.01% |
38,706
+632
| +2% | +$4.65K |
|
3066
Kodak
KODK
$809M
| $138K | ﹤0.01% |
46,530
+13,330
| +40% | +$40.5K |
|
3067
Fortress Biotech
FBIO
$111M
| $135K | ﹤0.01% |
5,044
+1,251
| +33% | +$32.8K |
|
|
TTPH
3068
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $135K | ﹤0.01% |
5,033
-2,743
| -35% | -$69.8K |
|
3069
Safe Bulkers
SB
$772M
| $134K | ﹤0.01% |
91,780
| – | – |
|
3070
Viridian Therapeutics
VRDN
$2.2B
| $134K | ﹤0.01% |
3,200
| – | – |
|
|
ENT
3071
DELISTED
Global Eagle Entertainment Inc.
ENT
| $134K | ﹤0.01% |
7,509
+931
| +14% | +$53K |
|
|
LLEX
3072
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
| $134K | ﹤0.01% |
113,732
+28,432
| +33% | +$49.1K |
|
3073
NextDecade
NEXT
$1.68B
| $133K | ﹤0.01% |
24,004
+316
| +1% | +$1.32K |
|
|
MARK
3074
DELISTED
Remark Holdings, Inc.
MARK
| $133K | ﹤0.01% |
7,179
+2,089
| +41% | +$42.5K |
|
3075
Fennec Pharmaceuticals
FENC
$335M
| $132K | ﹤0.01% |
27,211
+6,111
| +29% | +$40.2K |
|
Similar funds
Charles Schwab's Q1 2019 Portfolio in Review
As of Q1 2019, Charles Schwab held 3,256 positions worth $156B, up 20% from $131B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $7.96B of net new capital in Q1 2019, opening 111 new positions and adding to 2,472 existing holdings. Its largest new stake was Fox Class A: 1,745,328 shares worth $64.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Walmart Inc, an estimated $356M trimmed.
- Charles Schwab's largest Q1 2019 buy was Fox Class A: 1,745,328 shares worth $64.1M.
- Charles Schwab added most to Coca-Cola in Q1 2019, an estimated $443M increase.
- Charles Schwab's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $356M.
- Charles Schwab fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $213M.
- Charles Schwab's ten largest holdings make up 14% of its $156B portfolio in Q1 2019.
- Charles Schwab opened 111 new positions and closed 64 in Q1 2019.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $156B.
Based on Charles Schwab's 13F filing for Q1 2019, filed 14 May 2019.